🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In registry studies of CAR-T products that have been marketed globally, pat...
Status
Unknown
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2023-06-10
Trial ID
NCT05871684
Treatments Being Tested
This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2026-06-16
Trial ID
NCT07629817
This is a multicenter, single-arm, phase II clinical study evaluating the e...
Status
Enrolling By Invitation
Location
The First People's Hospital of Foshan
Start Date
2026-04-20
Trial ID
NCT07618624
DELTA-2 is a phase 1 clinical trial to evaluate the safety, feasibility, an...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-08
Trial ID
NCT05393635
Treatments Being Tested
This study is a single-center, randomized controlled, phase II clinical tri...
Status
Unknown
Location
Multiple Locations
Start Date
2020-03-01
Trial ID
NCT04252365
Treatments Being Tested
This study is a prospective, real-world study intended to evaluate the effi...
Status
Recruiting
Location
Jinling Hospital, Nanjing University Medical School
Start Date
2025-12-26
Trial ID
NCT07769827
Treatments Being Tested
This is a multi-center, randomized controlled, prospective clinical study....
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-12-22
Trial ID
NCT07248956
To further validate the performance of the high-sensitivity MRD assay in pa...
Status
Recruiting
Location
Cancer hospital, CAMS
Start Date
2024-07-16
Trial ID
NCT06498752
Treatments Being Tested
In this study, the investigators provide a combined treatment of personaliz...
Status
Recruiting
Location
First Affiliated Hospital of Nanchang University
Start Date
2024-09-01
Trial ID
NCT06751914
Treatments Being Tested
The study will evaluate the clinical activity of PD-(L)1 Checkpoint Inhibit...
Status
Terminated
Location
The University of Arizona Cancer Center
Start Date
2018-09-11
Trial ID
NCT03606174
Treatments Being Tested